Skip to main content
Year archive

Regent Pacific Group Limited — 2018 filings

All 32 regulatory filings released by Regent Pacific Group Limited (575) in 2018, sourced directly from the official regulator.

32 Filings
2018 Period
2018 filings (32)
Filing Released Lang
Licence agreement with Orient EuroPharma for the commercial launch of Fortacin in select territories in Asia, ex The People's Republic of China
Capital/Financing Update
2018-12-21 English
Terms of Reference of the Remuneration Committee (12 December 2018)
Remuneration Information
2018-12-12 English
Terms of Reference of the Audit Committee (12 December 2018)
Governance Information
2018-12-12 English
Terms of Reference of the Nomination Committee (11 December 2018)
Governance Information
2018-12-12 English
Licence agreement with Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. for the commercial launch of Fortacin in The People's Republic of China
Regulatory Filings
2018-12-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2018-12-03 English
Successful registration of Fortacin in Hong Kong
Regulatory Filings
2018-11-06 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-11-01 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-10-02 English
Interim Report for the six months ended 30 June 2018
Interim / Quarterly Report
2018-09-27 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-09-03 English
Unaudited interim results for the six months ended 30 June 2018
Interim / Quarterly Report
2018-08-24 English
Notice of Board Meeting for unaudited interim results for the six months ended 30 June 2018
Regulatory Filings
2018-08-14 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2018-08-01 English
Fortacin update: US Food and Drug Administration progress
Regulatory Filings
2018-07-13 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-07-03 English
Poll results at Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements
2018-06-14 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-06-01 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-05-02 English
Notice of Annual General Meeting
AGM Information
2018-04-27 English
Form of Proxy for use at the Annual General Meeting to be held on 14 June 2018
AGM Information
2018-04-27 English
(1) Re-election of Directors&#x3b; (2) General mandate to issue new shares&#x3b; (3) General mandate to repurchase the Company's own shares&#x3b; and (4) Annual General Meeting for Year 2018
AGM Information
2018-04-27 English
Annual Report for the year ended 31 December 2017
Annual Report
2018-04-27 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2018-04-03 English
Receipt of Fortacin European first commercial sales payments
Regulatory Filings
2018-03-23 English
Audited final results for the year ended 31 December 2017
Annual Report
2018-03-23 English
Notice of Board Meeting for audited final results for the year ended 31 December 2017
Report Publication Announcement
2018-03-13 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2018-03-01 English
Fortacin update: European launch commenced
Capital/Financing Update
2018-02-13 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-02-01 English
Profit warning
Earnings Release
2018-01-26 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-01-02 English